IMMUNE-MEDIATED NECROTIZING MYOPATHY
Clinical trials for IMMUNE-MEDIATED NECROTIZING MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-MEDIATED NECROTIZING MYOPATHY trials appear
Sign up with your email to follow new studies for IMMUNE-MEDIATED NECROTIZING MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells aim to tame rare muscle disorders
Disease control Recruiting nowThis study tests a new treatment called CABA-201 for people with active inflammatory myopathy, a group of rare diseases where the immune system attacks muscles. The treatment uses a patient's own immune cells, modified to target and destroy certain immune cells that cause the dis…
Matched conditions: IMMUNE-MEDIATED NECROTIZING MYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
Patients with rare muscle diseases help decide what scientists should study next
Knowledge-focused Recruiting nowThis study asks people with rare myositis diseases (like dermatomyositis or inclusion body myositis) and their caregivers what they think researchers should focus on. Through online surveys and forums, the goal is to create a list of patient-driven research priorities. The study …
Matched conditions: IMMUNE-MEDIATED NECROTIZING MYOPATHY
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 10:28 UTC